Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Revenue: 2013-2024

Historic Revenue for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $3.1 billion.

  • Surgery Partners' Revenue rose 663.29% to $821.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year increase of 1014.3%. This contributed to the annual value of $3.1 billion for FY2024, which is 1352.39% up from last year.
  • Surgery Partners' Revenue amounted to $3.1 billion in FY2024, which was up 1352.39% from $2.7 billion recorded in FY2023.
  • In the past 5 years, Surgery Partners' Revenue registered a high of $3.1 billion during FY2024, and its lowest value of $1.9 billion during FY2020.
  • For the 5-year period, Surgery Partners' Revenue averaged around $2.5 billion, with its median value being $2.5 billion (2022).
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 156.71% in 2020, then skyrocketed by 1962.26% in 2021.
  • Surgery Partners' Revenue (Annual) stood at $1.9 billion in 2020, then increased by 19.62% to $2.2 billion in 2021, then increased by 14.12% to $2.5 billion in 2022, then grew by 8.03% to $2.7 billion in 2023, then grew by 13.52% to $3.1 billion in 2024.
  • Its last three reported values are $3.1 billion in FY2024, $2.7 billion for FY2023, and $2.5 billion during FY2022.